feed,title,long_url,short_url
Benzinga,FDA Staff Had Inclination Towards Rejecting Sarepta Duchenne Gene Therapy,https://benzinga.com/general/biotech/23/04/31789321/fda-staff-had-inclination-towards-rejecting-sarepta-duchenne-gene-therapy,https://da.gd/KQaXS
Benzinga,5 Value Stocks To Watch In The Energy Sector,https://benzinga.com/news/23/04/31789939/5-value-stocks-to-watch-in-the-energy-sector,https://da.gd/xDF1
